What Is a Patent?

A patent is a property right that a government grants for a limited time. Within that country, it lets the owner stop others from making, using, selling, offering to sell, or importing an invention. The United States Patent Act calls it "the right to exclude others" from those activities (35 U.S.C. § 154). A patent gives its owner no permission to use the invention, only the power to stop others from using it. In exchange, the owner publishes a description that teaches the public how the invention works.

At a Glance

  • What a patent is: A property right a government grants for a limited time
  • The right: To stop others from making, using, selling, offering to sell, or importing the claimed invention; not permission to use it yourself
  • Where: Only in the country that granted it; there is no worldwide patent
  • How long: 20 years from the nonprovisional filing date, or up to 21 years from a provisional filed first, if the maintenance fees are paid
  • What sets its value: What the claims cover, and how well they survive a challenge

What a patent means beyond that definition depends on who holds it and what they intend to do with it:

  • To a patent attorney, it is a right to exclude, defined entirely by its claims and written as the shortest description of the invention that is general enough to be valuable and specific enough to be valid.
  • To an accountant, it is an intangible asset whose balance-sheet value seldom matches what it is worth.
  • To a business executive, it is a period of exclusivity over a particular solution, which can support pricing, margins, and negotiating leverage.
  • To an investor or acquirer, it is evidence that the company owns something competitors cannot simply copy. It is also a matter of optics, because investors read a portfolio as a sign of how seriously the company takes its own future.
  • To a large technology company, it is a chess piece in a game played with thousands of patents across dozens of countries.
  • To a drug developer, it is one layer of protection alongside term extensions and regulatory exclusivities, with a clock that starts years before the product can be sold.
  • To a government, it is a privilege granted to encourage invention, which it can limit in defined circumstances.
  • To a value investor, it is a moat with a drain date.
  • To a critic, it is a toll on competition.
  • To a historian, it is one of the oldest bargains in commercial law: a period of protection in exchange for teaching the public something new.

All of these are correct, and each leaves something out. The definition we find most useful for a business combines them: a patent is a vehicle for creating value from invention. How much value a particular patent creates depends on what it covers, where and for how long it can be enforced, how well it survives a challenge, and how intelligently its owner uses it.

A Patent Is a Right to Exclude

The most common misunderstanding about patents is that a patent gives its owner the right to make and sell the invention. A patent is a negative right. It lets the owner stop others, and collect compensation when they do not stop.

The distinction has real consequences. A company that patents an improved surgical stapler can still infringe an earlier patent, owned by someone else, on the basic stapling mechanism its improvement relies on. Whether an invention can be patented and whether a product can be sold are separate questions, and a granted patent answers only the first one.

What a Patent Gives, and What It Doesn't

A patent gives its ownerA patent does not give its owner
The rightThe power to stop others from making, using, selling, offering to sell, or importing the claimed inventionPermission to make or sell the invention. An earlier patent owned by someone else can still block the product.
ScopeWhatever the claims coverCoverage of the title, the drawings, or the product the patent was filed to protect
PlaceProtection in the country that granted itWorldwide protection
Time20 years from the nonprovisional filing, or up to 21 years from a provisional filed first, if the maintenance fees are paidProtection after the term ends, when the public may use the invention freely
ValidityA presumption that the patent is validImmunity from challenge in court or before the patent office
The left column is what the owner pays for. Most unpleasant surprises come from the right one.

To obtain a patent, an applicant must show that the invention is the kind of thing the law allows to be patented, that it is new, and that it would not have been obvious to a skilled person in the field. The application must also describe the invention clearly enough that a skilled person could make and use it. A patent office examines the application against those requirements and grants the patent if they are met. A granted patent is presumed valid, but the presumption can be overcome. Anyone accused of infringement can challenge the patent in court or before the patent office, and a meaningful share of challenged patents are narrowed or cancelled.

An owner who finds an infringer has more options than a lawsuit, including proceedings that can stop infringing products at the border. Our FAQ on how a patent owner can stop infringement covers each one.

What Patent Claims Cover

The scope of a patent comes from its claims, the numbered sentences at the end of the document. The title, the drawings, and the product the patent was filed to protect do not set it. A competitor infringes only if its product or process falls within at least one claim. A patent with an impressive title and narrow claims may be commercially trivial, while a patent with an unremarkable title and well-written claims may control a market.

Any invention can be described in a single phrase or in a hundred pages, and both descriptions refer to the same thing. They differ in what they are worth. A description broad enough to cover things that already exist will be refused, or will fall to the first serious challenge if it slips through. A description narrow enough to be granted easily can be avoided by a competitor who changes one detail. The valuable description sits between those extremes. It is as short as the prior art allows and as hard as possible to design around, and finding it means knowing the invention, the prior art, and the market well enough to tell the essential details from the ones that simply reflect how the first prototype happened to be built. Patent lawyers can spend an afternoon arguing over a single word, and in a claim that afternoon is usually well spent.

Finding the Valuable Claim

Claim scope, from too narrow to too broad A horizontal scale of claim scope. On the left, a claim that is too narrow is granted easily but can be avoided by a competitor who changes one detail. In the middle, the valuable claim is as broad as the prior art allows and hard to design around. On the right, a claim broad enough to cover things that already exist is refused, or falls to the first serious challenge. Narrower claims Broader claims What already exists (the prior art) begins here Too narrow The valuable claim Too broad Granted easily, and avoidedjust as easily: a competitorchanges one detail As broad as the prior art allowsand hard to design around,with a description that supports it Covers things that alreadyexist: refused, or lost to thefirst serious challenge
A schematic. Where the prior art begins is different for every invention, which is why finding the line takes knowledge of the invention, the prior art and the market.

This is why two patents on the same product can be worth a fortune and nothing, respectively. It also accounts for most complaints about patents. People who say patents are useless have usually met claims written too narrowly, and people who say patents are absurdly broad have usually met claims that should not have survived examination. Our objective in every application we prepare is the shortest, most valuable set of claims that covers the invention as broadly as the law allows, supported by a disclosure strong enough to keep those claims defensible and valid. Length has nothing to do with it. What matters is how far the claims reach and how well they hold up.

For legal purposes, then, the invention is the description of the prototype that a competitor cannot avoid, and the prototype on the bench is only its first example.

The Patent Bargain: Disclosure for Exclusivity

Every patent comes from a trade between the inventor and the public. The inventor receives a limited period of exclusivity, and the public receives a complete description of the invention, which it may study at once and use freely after the patent expires. If the description does not actually teach a skilled person how to make and use the invention, the inventor has not kept their side of the bargain, and the patent can be lost.

The description is published early. Most applications are published about 18 months after their first filing date, whether or not a patent is ever granted, which means that filing an application also tells competitors what the company has done.

For that reason, every decision to patent should be weighed against keeping the invention as a trade secret. A trade secret can last indefinitely and requires no disclosure, but it offers no protection if a competitor develops the same thing independently or takes the product apart to learn how it works. A patent protects against both, for a fixed term and at the price of publication. We use a simple working rule:

  • Inventions that will be visible in the product, easy to reverse engineer, or likely to be developed independently are usually better patented.
  • Manufacturing methods, formulation know-how, training data, and other know-how that can be kept behind closed doors are often better kept there.

The strongest positions frequently combine the two, with patents on what the market can see and trade secrets on how it is made.

Patents as Business Assets

Executives often call a patent a monopoly, and in the right circumstances it can work like one. For many pharmaceutical, medical device, and specialty materials companies, a period of patent exclusivity is the business model. The exclusivity covers a claimed solution, though, and a market can usually be served in more than one way. The federal antitrust agencies make the same point: they "will not presume that a patent... necessarily confers market power upon its owner," because customers often have other ways to solve the same problem (DOJ and FTC Antitrust Guidelines). A patent on the only practical way to achieve a result comes close to a market monopoly. A patent on one of six interchangeable approaches is an inconvenience. The commercial test is how expensive, slow, or inferior it would be for a competitor to work around the claims.

On a balance sheet, a patent is an intangible asset, and its book value is often a poor guide to what it is worth. A patent bought in an acquisition may be carried at a substantial figure. An internally developed patent that protects the company's entire product line may be carried at almost nothing, because the research behind it was expensed as it was incurred. Book value, tax basis, and economic value are usually three different numbers, and only the economic value reflects what someone would pay for the right to exclude.

For investors and acquirers, patents are partly substance and partly optics. A portfolio tells the market that the founders have thought seriously about defensibility. A sophisticated investor looks past the patent count, however, and asks whether the claims cover the product the company will actually sell and whether competitors can avoid them. An acquirer asks less glamorous questions that matter just as much. Did every inventor sign an effective assignment? Is ownership properly recorded? Do university, government, or former-employer rights encumber the patents? Have the fees been paid? A patent is worth roughly what its claims cover multiplied by how much that coverage matters, discounted for the chance that the claims will be narrowed or invalidated and for the cost of enforcing them.

Patents in Large Technology Companies

In smartphones, semiconductors, networking, and artificial intelligence, a single product may involve thousands of patents owned by hundreds of companies, and no participant can sell anything without potentially infringing someone else's. Patents in that setting work more like chess pieces than fences. A portfolio deters lawsuits because any lawsuit will be met with counterclaims. Cross-licenses let companies trade access to each other's portfolios. Patents essential to an industry standard are usually licensed on fair, reasonable, and non-discriminatory terms. And a patent covering where a competitor is headed can be worth more than one covering what the owner sells today.

Consider a hypothetical consumer electronics company with a trillion-dollar market value. Call it Behemoth. Behemoth's lasting advantage comes from design, integration, supply chain, brand, and a disciplined culture of secrecy. Its patents have a narrower job, which is to make copying slow and conspicuous, so that Behemoth's lead keeps growing while a fast follower is tied up in court. Think of the patent as a speed tax on copyists. Behemoth values design patents as much as utility patents, because in the United States an infringer of a design patent can be required to give up its total profit on the infringing article (35 U.S.C. § 289). For a company that sells appearance as much as function, a patent on how a product looks can be worth as much as a patent on how it works.

Behemoth is also sued far more often than it sues. It wants strong protection for its own inventions and efficient procedures for challenging everyone else's, and it sees no contradiction in wanting both. It knows something smaller companies tend to underestimate: a small company holding one well-chosen patent can force even the largest company in an industry to pay a license fee, redesign a product, or switch off a feature. Behemoth has also learned to treat a product launch as a disclosure. The United States forgives an inventor's own public disclosure if the application is filed within one year, but most of Europe does not, so a product unveiled on stage before the application is filed may be a marketing triumph in one country and prior art in another.

A start-up will not win a patent war with Behemoth. It can own a small number of well-chosen pieces that Behemoth needs, and those pieces can decide whether the start-up is acquired, licensed, partnered with, or ignored.

Patents Are National

Each patent is granted by a particular country, or by a regional office acting for a group of countries, and it can be enforced only there. There is no worldwide patent. A company that wants protection in the United States, Europe, Japan, China, and India needs a patent granted in each of them. The international application system run by the World Intellectual Property Organization lets an applicant start the process in many countries with a single filing and postpone most national costs for about 30 months. Each country still decides for itself whether to grant a patent, because the system handles filing and leaves the granting to national offices (WIPO).

The countries also apply different rules, and medicine shows the differences most clearly:

  • In Europe, a method of treating a patient cannot be patented, but a compound "for use in" treating a disease can be.
  • In the United States, methods of treatment can be patented, but a patent owner generally cannot sue a doctor for performing a medical procedure.
  • India has refused patents on new forms of known drugs unless the new form works better therapeutically, including in a well-known refusal involving a leading cancer drug (UNCTAD).

The same invention therefore needs claims written differently for each major market.

Europe has also redrawn its own map. Since 2023, the owner of a European patent can choose a single Unitary Patent covering 18 European Union countries, enforced in one new court, the Unified Patent Court. Renewal fees for a Unitary Patent total EUR 35,555 (about $39,000) over 20 years, compared with about EUR 124,440 (about $137,000) to keep a conventional European patent in force in the same 18 countries (European Patent Office). The dollar figures use the European Central Bank reference rate of November 20, 2026. The tradeoff is that one ruling can enforce the patent in all of those countries at once, and one ruling can also revoke it in all of them (European Patent Office).

Renewal Fees Over 20 Years in the 18 Unitary Patent Countries

Unitary Patent (one patent, one fee)
EUR 35,555 (about $39,000)
Conventional European patent (a national fee in each of the 18 countries)
EUR 124,440 (about $137,000)
Renewal fees only, from the European Patent Office's comparison based on national fees as of April 1, 2026. Dollar figures use the European Central Bank reference rate of November 20, 2026.

Many people believe that a serious company should file in every major market it can afford, and that a patent family is worth more the more countries it covers. The belief is common, and it is usually mistaken. A patent adds value in a country only if it protects revenue the owner expects to earn there, or blocks a competitor where that competitor must manufacture, export, or obtain regulatory approval. If the United States and Europe will produce 80 percent of a product's revenue, patents in those two markets may capture nearly all the value a worldwide family would, at a fraction of the cost. We ask clients where the power to exclude would change the economics, which is a shorter list than where a patent can be obtained.

How Long a Patent Lasts

A U.S. utility patent lasts 20 years from the filing date of its nonprovisional application. The year a provisional application is pending does not count, so a patent that begins with a provisional can last up to 21 years from the first filing (USPTO). Either way, the maintenance fees must be paid at 3.5, 7.5, and 11.5 years after grant (USPTO). For most technologies, the owner can sell the product for most of that time. For drugs, biologics, and many medical devices, the owner cannot. The patent has to be filed early, often before the first patient is treated, and the clock then runs through years of clinical trials and regulatory review during which the product cannot be sold at all.

The Life of a U.S. Utility Patent

The life of a U.S. utility patent, from the first filing to expiry A bar drawn to scale over 21 years from the filing of a provisional application. The provisional is pending for one year, and the nonprovisional application is filed at the end of that year; the 20-year term is counted from that filing. The application is then pending until grant, shown here at year 4. From grant the patent is in force if maintenance fees are paid, at 3.5, 7.5 and 11.5 years after grant. The patent expires 20 years from the nonprovisional filing date, which is up to 21 years from the provisional filing date, unless a patent term adjustment or extension applies. Provisional filed Sets the priority date; the term has not started Expiry 20 years from the nonprovisional, up to 21 years from the provisional 1 yr Pending Patent in force, if the maintenance fees are paid NonprovisionalGrantFee dueFee dueFee due filed by year 1;the term starts Timing varies;year 4 shown 3.5 yearsafter grant 7.5 yearsafter grant 11.5 yearsafter grant Adjustment orextension,where available Year 0510152021
Drawn to scale for an application that begins with a provisional, with the nonprovisional filed at the 12-month deadline and grant shown three years later for illustration. The 20-year term runs from the earliest U.S. nonprovisional or international (PCT) filing date to which the patent claims benefit. The provisional year does not count, so filing a provisional first can push the expiry date out by as much as 12 months (USPTO); a foreign priority year works the same way. Each maintenance fee may be paid in the six months before it is due or, with a surcharge, in the six months after; if it is not paid by then, the patent expires. Design patents last 15 years from grant and carry no maintenance fees.

Governments restore part of that lost time. In the United States, a patent covering an approved drug or device can be extended by up to five years to make up for time spent in regulatory review, within overall limits, and Europe and Japan offer similar extensions. Regulators also grant periods of exclusivity that do not depend on any patent, for example for new chemical entities, orphan drugs, and biologics. For a life sciences company, exclusivity ends on the latest of the extended patent term and the regulatory exclusivities available in each major market, and planning for that date should begin long before approval.

Government Limits on Patents

A government that grants a patent keeps certain powers over it. Under international trade rules, a country may authorize others to use a patented invention without the owner's consent in defined circumstances, usually in exchange for adequate compensation (World Trade Organization). This is called a compulsory license. The best-known example involves the combination therapies that turned HIV into a manageable disease. At the end of the 1990s, these treatments cost roughly $10,000 to $15,000 per patient per year. In 2001, an Indian generic manufacturer offered a combination regimen for $350 per year (Journal of the International AIDS Society), and several governments later issued compulsory licenses for HIV medicines.

The United States has its own versions of these powers. Under the Bayh-Dole Act, a federal agency that funded an invention may "march in" and require the patent owner to license others in limited circumstances, though no agency has ever done so. The federal government may also use any patented invention, leaving the owner a claim for compensation instead of an injunction. These powers are rarely used, and we treat them as terms of the grant to be managed when advising clients.

How a Patent Can Lose Value

A patent can be damaged by its owner's own conduct as easily as by a competitor's attack. Value can be lost:

  • at the drafting stage, through claims that are too narrow or a description that does not support them;
  • during examination, through statements made to the examiner or a failure to disclose known prior art;
  • in the market, through unmarked products, poorly structured licenses, or authorized sales that end the patent's control over the products sold;
  • through delay in dealing with infringers, or through conduct a court considers unfair.

A few of these losses are deliberate choices that turned out badly. Most are accidents that sat unnoticed for years until an opponent in litigation found them. Our FAQ on how a patent can lose its value sets them out from a litigator's perspective.

History of the Patent System

Renaissance Venice enacted a patent statute in 1474, granting ten years of exclusivity to anyone who built a new and ingenious device in the city (Santa Clara Law). England granted its first known invention patent in 1449, to John of Utynam for a method of making stained glass (UK Government). Under Elizabeth I and James I, the English Crown abused the device by handing courtiers monopolies over ordinary goods such as playing cards. Parliament responded with the Statute of Monopolies of 1624, which abolished monopolies generally but preserved grants of limited duration for "the true and first inventor" of new manufactures (Primary Sources on Copyright). That statute turned exclusivity from a royal favor, available to whoever had the monarch's attention, into a legal entitlement available to anyone who actually invented something.

The framers of the U.S. Constitution adopted the English model deliberately, empowering Congress to promote progress by "securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries" (Constitution Annotated). Abraham Lincoln, the only U.S. president to hold a patent, said the patent system "added the fuel of interest to the fire of genius" (USPTO).

The history also bears on the sharpest criticism of patents, that they make the rich richer. Before patent systems existed, knowledge was guarded by guilds and families, and it often died with them. Without patents, exclusivity would belong to whoever could best keep a secret, which usually means companies with closed factories, controlled supply chains, and the resources to sue. A patent remains one of the few forms of exclusivity that an individual inventor, a university laboratory, or a five-person start-up can obtain on the same terms as the largest company in its field, and it lets a clever person profit from cleverness without first accumulating capital. We support the patent system for that reason. It is imperfect and has to be used with discipline, and for more than five centuries it has been the most reliable means any society has found to reward people for bringing new things into the world and then teaching everyone else how they work.

Four Ways to Think About a Patent

A Moat With a Drain Date

Warren Buffett built a fortune without relying on patents, which makes his framework a useful test of what they are worth. He defined an economic franchise as a product that "(1) is needed or desired; (2) is thought by its customers to have no close substitute and; (3) is not subject to price regulation" (Berkshire Hathaway, 1991 Letter). A patent can create the second condition by law, because during its term the customer has no lawful close substitute for what the claims cover. No law creates demand, so a patent cannot supply the first condition, and in medicine it runs into the third, because governments regulate drug prices.

A patent is a moat with its drain date printed on the front. During the term, the owner's real work is to build the moat that will outlast it: brand, installed base, switching costs, manufacturing scale, data, and the next generation of patents. Buffett praised businesses that spent years "widening the 'moats'" around themselves (Berkshire Hathaway, 2008 Letter), and a patent gives its owner a fixed period in which to start digging.

A Revenue Forecast With an End Date

To the general counsel of a pharmaceutical company, a patent is a line in the revenue forecast, and the date that line ends matters more than anything else about it. Novartis's 2025 annual report said that after the company "lost market exclusivity for Entresto in the US in July 2025," it "experienced a substantial decline in Entresto sales in that market" (Novartis Annual Report 2025). Seen from that office, a drug company is a portfolio of expiring exclusivities. The patent that matters most is often the last defensible one, which sets the date of the cliff, rather than the first one filed, which defines the molecule.

A Peace Treaty

Some companies file patents mainly so that they can promise not to use them. OpenAI, for example, pledges to use its patents only defensively, unless someone asserts a patent claim against it or engages in other specified hostile conduct (OpenAI). A promise not to sue carries weight only when there are patents behind it. A company with a substantial portfolio can offer peace on stated terms, attract partners to its platform, and keep a deterrent in reserve for anyone who breaks the truce.

An Option

Economists have long treated patents as options. A landmark study estimated what patents were worth from whether their owners kept paying renewal fees, and found that a few patents are worth a great deal while most are worth little (Pakes, Econometrica). Each maintenance fee is a premium paid to keep the option alive for another period. An owner that pays every fee on every patent is holding every option to expiry, whether or not the underlying market ever moved. We recommend reviewing the portfolio at each fee date, keeping the patents that cover what competitors must do, and letting the rest lapse without sentiment. Lawyers are sentimental about very little, but we can grow attached to a patent family we spent three years prosecuting, which is one more reason to put the review on the docket.

What a Patent Should Do for You

A patent is a government-granted right to exclude others from what its claims describe, for a limited time and within a particular country. It is granted in exchange for teaching the public how the invention works, and it can be challenged, limited, or lost. It is also an asset, a strategic position, a moat with a drain date, and an option whose premiums come due every few years. A patent creates value when it covers what competitors must do, in the places where exclusion matters, for as long as the product needs protection, and when it is built to survive the scrutiny its success will attract. A patent obtained for its own sake rarely creates any.

The statute will tell you what a patent is. Deciding what yours should do for your business is the part worth planning, and the time to plan it is before the first public disclosure. If you have an invention and a business that depends on it, talk to us.

This FAQ provides general information, not legal advice, and does not create an attorney-client relationship. Outcomes depend on specific facts and jurisdictions. See our Legal Notices.

Related